Cargando…
Patient Perspectives on Novel Treatments in Haemophilia: A Qualitative Study
BACKGROUND AND OBJECTIVE: New treatments for haemophilia are under development or entering the market, including extended half-life products, designer drugs and gene therapy, thereby increasing treatment options for haemophilia. It is currently unknown how people with haemophilia decide whether to s...
Autores principales: | van Balen, Erna C., Wesselo, Marjolein L., Baker, Bridget L., Westerman, Marjan J., Coppens, Michiel, Smit, Cees, Driessens, Mariëtte H. E., Leebeek, Frank W. G., van der Bom, Johanna G., Gouw, Samantha C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075838/ https://www.ncbi.nlm.nih.gov/pubmed/31691206 http://dx.doi.org/10.1007/s40271-019-00395-6 |
Ejemplares similares
-
Similar sports participation as the general population in Dutch persons with haemophilia; results from a nationwide study
por: Versloot, Olav, et al.
Publicado: (2021) -
Socioeconomic participation of persons with hemophilia: Results from the sixth hemophilia in the Netherlands study
por: van Balen, Erna C., et al.
Publicado: (2022) -
Validation of PROMIS Profile‐29 in adults with hemophilia in the Netherlands
por: van Balen, Erna C., et al.
Publicado: (2021) -
Health and treatment outcomes of patients with hemophilia in the Netherlands, 1972–2019
por: Hassan, Shermarke, et al.
Publicado: (2021) -
Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001–2018
por: Hassan, Shermarke, et al.
Publicado: (2020)